Small Molecule Receptor Agonists and Antagonists of CCR3 Provide Insight into Mechanisms of Chemokine Receptor Activation

This publication has 47 references indexed in Scilit:

• Predictions of CCR1 Chemokine Receptor Structure and BX 471 Antagonist Binding Followed by Experimental Validation
  Journal of Biological Chemistry, 2006
• Alanine scanning mutagenesis of the chemokine receptor CCR3 reveals distinct extracellular residues involved in recognition of the eotaxin family of chemokines
  Molecular Immunology, 2006
• Identification and Characterization of a Potent, Selective Nonpeptide Agonist of the CC Chemokine Receptor CCR8
  Molecular Pharmacology, 2006
• Genetic variation in G-protein-coupled receptors – consequences for G-protein-coupled receptors as drug targets
  Emerging Therapeutic Targets, 2005
• The carboxyl terminus of the chemokine receptor CCR3 contains distinct domains which regulate chemotactic signaling and receptor down‐regulation in a ligand‐dependent manner
  European Journal of Immunology, 2005
• Site-directed Mutagenesis of CC Chemokine Receptor 1 Reveals the Mechanism of Action of UCB 35625, a Small Molecule Chemokine Receptor Antagonist
  Published by Elsevier ,2005
• A role for eosinophils in airway remodelling in asthma
  Trends in Immunology, 2004
• The CC Chemokine Eotaxin (CCL11) Is a Partial Agonist of CC Chemokine Receptor 2b
  Journal of Biological Chemistry, 2001
• Tryptase-Chymase Double-Positive Human Mast Cells Express the Eotaxin Receptor CCR3 and Are Attracted by CCR3-Binding Chemokines
  The American Journal of Pathology, 1999
• Backbone dynamics of the human cc chemokine eotaxin: Fast motions, slow motions, and implications for receptor binding
  Protein Science, 1999